Generate a tailored SOP for Dr. Jason Lewis. Improve your application with a focused, well-structured draft.
Jason S. Lewis is the Deputy Director of the Sloan Kettering Institute and the Emily Tow Chair in Oncology. His research focuses on the development of innovative radiopharmaceuticals that are pivotal for targeted diagnosis and treatment of cancer. He works on combining small biomolecule-based targeting agents with positron-emitting therapeutic radioisotopes to interrogate cancer's molecular profile using non-invasive nuclear imaging techniques. His primary interest lies in advancing novel radiopharmaceuticals for clinical translation, with particular emphasis on nonstandard nuclides in molecular imaging. Through his leadership in the Lewis Lab, he aims to bring cutting-edge radiochemistry into clinical practice, improving patient outcomes in oncology therapies.
Sloan Kettering Institute • New York, NY
Oversees research operations and initiatives in molecular pharmacology and radiochemistry.
Administered through the Gerstner Sloan Kettering (GSK) Graduate School. The program focus is Cancer Biology and includes faculty from the Department of Molecular Pharmacology.